NOVARTIS N (NOT.SG)
NOVARTIS N (NOT.SG) operates in Diversified Metals & Mining.
Market Cap & Net Worth: NOVARTIS N (NOT.SG) (NOT)
NOVARTIS N (NOT.SG) (STU:NOT) has a market capitalization of $1.25 Million (€1.22 Million) as of March 19, 2026. Listed on the STU stock exchange, this Germany-based company holds position #35545 globally and #4218 in its home market, demonstrating a -3.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NOVARTIS N (NOT.SG)'s stock price €134.15 by its total outstanding shares 9112 (9.11K).
NOVARTIS N (NOT.SG) Market Cap History: 2015 to 2026
NOVARTIS N (NOT.SG)'s market capitalization history from 2015 to 2026. Data shows growth from $485.77K to $1.25 Million (9.26% CAGR).
NOVARTIS N (NOT.SG) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NOVARTIS N (NOT.SG)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
NOVARTIS N (NOT.SG)'s market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
NOVARTIS N (NOT.SG)'s market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $485.77K | $50.39 Billion | $17.78 Billion | 0.00x | 0.00x |
| 2016 | $433.06K | $49.44 Billion | $6.71 Billion | 0.00x | 0.00x |
| 2017 | $461.01K | $50.13 Billion | $7.70 Billion | 0.00x | 0.00x |
| 2018 | $506.46K | $53.17 Billion | $12.61 Billion | 0.00x | 0.00x |
| 2019 | $568.64K | $48.68 Billion | $11.73 Billion | 0.00x | 0.00x |
| 2020 | $591.89K | $49.90 Billion | $8.07 Billion | 0.00x | 0.00x |
| 2021 | $616.51K | $43.97 Billion | $24.02 Billion | 0.00x | 0.00x |
| 2022 | $643.05K | $43.46 Billion | $6.96 Billion | 0.00x | 0.00x |
| 2023 | $671.66K | $46.66 Billion | $14.85 Billion | 0.00x | 0.00x |
Competitor Companies of NOT by Market Capitalization
Companies near NOVARTIS N (NOT.SG) in the global market cap rankings as of March 19, 2026.
Key companies related to NOVARTIS N (NOT.SG) by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
NOVARTIS N (NOT.SG) Historical Marketcap From 2015 to 2026
Between 2015 and today, NOVARTIS N (NOT.SG)'s market cap moved from $485.77K to $ 1.25 Million, with a yearly change of 9.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.25 Million | +13.64% |
| 2025 | €1.10 Million | +57.17% |
| 2024 | €702.53K | +4.60% |
| 2023 | €671.66K | +4.45% |
| 2022 | €643.05K | +4.30% |
| 2021 | €616.51K | +4.16% |
| 2020 | €591.89K | +4.09% |
| 2019 | €568.64K | +12.28% |
| 2018 | €506.46K | +9.86% |
| 2017 | €461.01K | +6.45% |
| 2016 | €433.06K | -10.85% |
| 2015 | €485.77K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NOVARTIS N (NOT.SG) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.25 Million USD |
| MoneyControl | $1.25 Million USD |
| MarketWatch | $1.25 Million USD |
| marketcap.company | $1.25 Million USD |
| Reuters | $1.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.